Siga este enlace para ver otros tipos de publicaciones sobre el tema: Treatment options.

Artículos de revistas sobre el tema "Treatment options"

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Treatment options".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

Ndukwe, Munachiso Onyedikachi, Ivan Práznovec, Martin Štěpán, Igor Sirák, Aleš Fibír y Jiří Špaček. "Treatment options for locally recurrent vulvar cancer". Česká gynekologie 86, n.º 4 (30 de agosto de 2021): 246–48. http://dx.doi.org/10.48095/cccg2021246.

Texto completo
Resumen
Summary: Objective: Summarizing of treatment options for locally recurrent vulvar cancer in patients after previous complex oncological treatment and presenting a case report from our department. Methods: Presenting a case report of a patient after previous complex oncological treatment for spinocellular cancer of the vulva who presented with a locally recurrent tumor. The patient was treated with a wide radical local excision of the tumor followed by a posterior thigh fl ap graft. Conclusion: Surgical intervention is the primary mode of treatment in locally recurrent cancers of the vulva. Wide radical local excision as a mode of treatment can be optimized by the use of grafts aiding in wound healing.
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Erkinjuntti, Timo. "Treatment options". Journal of the Neurological Sciences 203-204 (noviembre de 2002): 125–30. http://dx.doi.org/10.1016/s0022-510x(02)00267-8.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Steinbeck, Katharine. "Treatment options". Best Practice & Research Clinical Endocrinology & Metabolism 19, n.º 3 (septiembre de 2005): 455–69. http://dx.doi.org/10.1016/j.beem.2005.04.010.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Krupa Muniyandi, Divya. "Newer Treatment Options and Ongoing Research in Oncology". Indian Journal of Cancer Education and Research 8, n.º 1 (1 de junio de 2020): 39–44. http://dx.doi.org/10.21088/ijcer.2321.9815.8120.6.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Capozzi, James D., Rosamond Rhodes y Darwin Chen. "Discussing Treatment Options". Journal of Bone and Joint Surgery-American Volume 91, n.º 3 (marzo de 2009): 740–42. http://dx.doi.org/10.2106/jbjs.h.01104.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Kadir, Rezan A. "Menorrhagia: treatment options". Thrombosis Research 123 (enero de 2009): S21—S29. http://dx.doi.org/10.1016/s0049-3848(09)70005-2.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

GILLETT, E. "HYPERLIPID TREATMENT OPTIONS". Clinics in Family Practice 4, n.º 3 (septiembre de 2002): 567–83. http://dx.doi.org/10.1016/s1522-5720(02)00017-x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Golzarian, Jafar, Earl B. Maes y Shiliang Sun. "Endoleak: Treatment Options". Techniques in Vascular and Interventional Radiology 8, n.º 1 (marzo de 2005): 41–49. http://dx.doi.org/10.1053/j.tvir.2005.06.001.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Ramasamy, V., A. Williams, R. Pyart, D. Glover, S. W. Robertson, B. Thomas, T. Kristensen et al. "AKI TREATMENT OPTIONS". Nephrology Dialysis Transplantation 29, suppl 3 (1 de mayo de 2014): iii1—iii2. http://dx.doi.org/10.1093/ndt/gfu107.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Parker, Cindy Schott. "Wound Treatment Options". Home Health Care Management & Practice 10, n.º 3 (abril de 1998): 30–35. http://dx.doi.org/10.1177/089780189801000306.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
11

Naclerio. "Optimizing treatment options". Clinical & Experimental Allergy 28, S6 (diciembre de 1998): 54–59. http://dx.doi.org/10.1046/j.1365-2222.1998.0280s6054.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
12

Barber, F. Alan. "Meniscal Treatment Options". Sports Medicine and Arthroscopy Review 20, n.º 2 (junio de 2012): 57. http://dx.doi.org/10.1097/jsa.0b013e31823a011b.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
13

Pawlik Plank, Darlene M. "Framing Treatment Options". Clinical Nurse Specialist 8, n.º 4 (julio de 1994): 174–78. http://dx.doi.org/10.1097/00002800-199407000-00002.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
14

Malberti, Fabio. "Hyperphosphataemia: Treatment Options". Drugs 73, n.º 7 (27 de abril de 2013): 673–88. http://dx.doi.org/10.1007/s40265-013-0054-y.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
15

Andersson, K. E. "LUTS treatment: Future treatment options". Neurourology and Urodynamics 26, S6 (2007): 934–47. http://dx.doi.org/10.1002/nau.20500.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
16

Chamberlain, Marc C. "Treatment options for glioblastoma". Neurosurgical Focus 20, n.º 4 (abril de 2006): E19. http://dx.doi.org/10.3171/foc.2006.20.4.12.

Texto completo
Resumen
✓ Following the seminal trial conducted by the European Organisation for Research and Treatment of Cancer (EORTC) and the National Cancer Institute of Canada (NCIC), concurrent temozolomide and radiotherapy has become the new standard of care for patients with newly diagnosed glioblastoma multiforme (GBM). Investigation of emerging therapies (which are now used as salvage therapy) such as small-molecule inhibitors (for example, epidermal growth factor receptor inhibitors) and convection-enhanced delivery (CED) of targeted toxins (for example, interleukin-13/pseudo-monas exotoxin) is likely to build on the EORTC/NCIC treatment platform and will, it is hoped, improve survival rates in patients with GBM. The majority of adjuvant Phase I and II trials being conducted by the brain tumor consortia are based on the EORTC/NCIC treatment platform and have added a targeted therapy in an effort to find a promising synergistic treatment. Furthermore, researchers in the consortia are continuing to explore treatments for recurrent GBM, not otherwise eligible for local therapies, such as CED. The treatments under study include novel cytotoxic chemotherapy as well as small-molecule inhibitors; these are being assessed in a variety of Phase I or II trials.
Los estilos APA, Harvard, Vancouver, ISO, etc.
17

Hansen, Frederick, Michael A. Jarvis, Heinz Feldmann y Kyle Rosenke. "Lassa Virus Treatment Options". Microorganisms 9, n.º 4 (7 de abril de 2021): 772. http://dx.doi.org/10.3390/microorganisms9040772.

Texto completo
Resumen
Lassa fever causes an approximate 5000 to 10,000 deaths annually in West Africa and cases have been imported into Europe and the Americas, challenging public health. Although Lassa virus was first described over 5 decades ago in 1969, no treatments or vaccines have been approved to treat or prevent infection. In this review, we discuss current therapeutics in the development pipeline for the treatment of Lassa fever, focusing on those that have been evaluated in humans or animal models. Several treatments, including the antiviral favipiravir and a human monoclonal antibody cocktail, have shown efficacy in preclinical rodent and non-human primate animal models and have potential for use in clinical settings. Movement of the promising preclinical treatment options for Lassa fever into clinical trials is critical to continue addressing this neglected tropical disease.
Los estilos APA, Harvard, Vancouver, ISO, etc.
18

Shanmugam, Dr S. y Dr Manoharan Manoharan. "Study on Incidence, Types and Treatment Options of Carcinoma Penis". Scholars Journal of Applied Medical Sciences 4, n.º 6 (junio de 2016): 1919–21. http://dx.doi.org/10.21276/sjams.2016.4.6.10.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
19

Naegel, Steffen, Manjit Matharu y Mark Obermann. "Treatment Options for Vestibular Migraine". US Neurology 12, n.º 01 (2016): 39. http://dx.doi.org/10.17925/usn.2016.12.01.39.

Texto completo
Resumen
Although vestibular migraine is a common cause of vertigo, affecting approximately 1% of the Western world’s population, it remains widely under-recognized and is under-diagnosed. Diagnostic criteria for vestibular migraine were recently published in collaboration with the International Headache Society and the Bárány-Society. Trials investigating the treatment of vestibular migraine are sparse but some are now underway. This review focuses on the treatments options available for vestibular migraine, based on the existing evidence base where available. Regarding acute treatments, there are two randomized controlled trials that provide evidence for the use of triptans (zolmitriptan and rizatriptan) for the management of vestibular migraine attacks. For prophylactic treatment, the evidence base is largely non-existent, since the only multicenter randomized placebo-controlled trial testing metoprolol versus placebo is still underway. Consequently, the treatment recommendations for the prophylactic treatment of vestibular migraine are mainly based on expert opinion and the treatments guidelines for migraine with and without aura.
Los estilos APA, Harvard, Vancouver, ISO, etc.
20

Granet, David B., William Christian, Cintia F. Gomi, Lydia Banuelos y Erika Castro. "Treatment Options for Anisohyperopia". Journal of Pediatric Ophthalmology and Strabismus 43, n.º 4 (1 de julio de 2006): 207–11. http://dx.doi.org/10.3928/01913913-20060701-01.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
21

OʼDriscoll, Shawn W. "Elbow Arthritis: Treatment Options". Journal of the American Academy of Orthopaedic Surgeons 1, n.º 2 (noviembre de 1993): 106–16. http://dx.doi.org/10.5435/00124635-199311000-00005.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
22

Hak, David J. y Gregory J. Golladay. "Olecranon Fractures: Treatment Options". Journal of the American Academy of Orthopaedic Surgeons 8, n.º 4 (julio de 2000): 266–75. http://dx.doi.org/10.5435/00124635-200007000-00007.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
23

Khosla, Sundeep y B. Lawrence Riggs. "Treatment Options for Osteoporosis". Mayo Clinic Proceedings 70, n.º 10 (octubre de 1995): 978–82. http://dx.doi.org/10.4065/70.10.978.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
24

Walling, Hobart W. y Brian L. Swick. "Treatment Options for Hyperhidrosis". American Journal of Clinical Dermatology 12, n.º 5 (octubre de 2011): 285–95. http://dx.doi.org/10.2165/11587870-000000000-00000.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
25

Weekes, Lynn M., Ken K. Ho y J. Paul Seale. "Treatment Options in Acromegaly". PharmacoEconomics 10, n.º 5 (noviembre de 1996): 453–59. http://dx.doi.org/10.2165/00019053-199610050-00002.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
26

&NA;. "Postmenopausal osteoporosis: treatment options". Inpharma Weekly &NA;, n.º 1342 (junio de 2002): 2. http://dx.doi.org/10.2165/00128413-200213420-00001.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
27

Sherwood, IAnand. "Fluorosis varied treatment options". Journal of Conservative Dentistry 13, n.º 1 (2010): 47. http://dx.doi.org/10.4103/0972-0707.62631.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
28

Familiari, Pietro, Santi Greco, Ance Volkanovska, Giovanni Gigante, Anna Cali, Ivo Boškoski y Guido Costamagna. "Achalasia: current treatment options". Expert Review of Gastroenterology & Hepatology 9, n.º 8 (17 de julio de 2015): 1101–14. http://dx.doi.org/10.1586/17474124.2015.1052407.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
29

Lopez, Roberto Gabriel L. y Hong-Geun Jung. "Achilles Tendinosis: Treatment Options". Clinics in Orthopedic Surgery 7, n.º 1 (2015): 1. http://dx.doi.org/10.4055/cios.2015.7.1.1.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
30

Sheppard, M. C. y P. M. Stewart. "Treatment options for acromegaly". Metabolism 45 (agosto de 1996): 63–64. http://dx.doi.org/10.1016/s0026-0495(96)90085-2.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
31

Wray, Betty B. "Asthma: best treatment options". Annals of Allergy, Asthma & Immunology 87, n.º 1 (julio de 2001): 9–12. http://dx.doi.org/10.1016/s1081-1206(10)62189-8.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
32

Dunn, Maria L., Elizabeth B. Cockerline y Mitchell R. Rice. "Treatment Options for Psoriasis". American Journal of Nursing 88, n.º 8 (agosto de 1988): 1081. http://dx.doi.org/10.2307/3470955.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
33

Starostina, L. S. "Prolonged cough: treatment options". Pediatrics (Suppl Consilium Medicum), n.º 1 (2015): 70–72. http://dx.doi.org/10.26442/2413-8460_2016.1.70-72.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
34

RAVIKUMAR, A., PRAKASH SINGH y VK BATISH. "FACIAL PALSY - TREATMENT OPTIONS". Medical Journal Armed Forces India 55, n.º 1 (enero de 1999): 41–44. http://dx.doi.org/10.1016/s0377-1237(17)30312-x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
35

Attarian, Hrayr. "Treatment Options for Parasomnias". Neurologic Clinics 28, n.º 4 (noviembre de 2010): 1089–106. http://dx.doi.org/10.1016/j.ncl.2010.03.025.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
36

Martin Liberal, Juan, Ian Judson y Charlotte Benson. "Treatment options for leiomyosarcoma". Expert Opinion on Orphan Drugs 1, n.º 5 (25 de marzo de 2013): 413–22. http://dx.doi.org/10.1517/21678707.2013.783769.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
37

Mayer, Geert, Claudio LA Bassetti y Yves Dauvilliers. "Treatment options in narcolepsy". Expert Opinion on Orphan Drugs 1, n.º 12 (5 de noviembre de 2013): 987–99. http://dx.doi.org/10.1517/21678707.2013.854701.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
38

King, Brent R. "Treatment Options for Sinusitis". Emergency Medicine News 25, n.º 3 (marzo de 2003): 12. http://dx.doi.org/10.1097/00132981-200303000-00012.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
39

L.N, Sunil Kumar, Pradnya Nagmode, Varsha Tambe, Sumeet Gonmode y Fareedi Mukram Ali. "MIDLINE DIASTEMA: TREATMENT OPTIONS". Journal of Evolution of medical and Dental Sciences 1, n.º 6 (31 de diciembre de 2012): 1267–72. http://dx.doi.org/10.14260/jemds/206.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
40

Panje, Cédric M., Markus Glatzer, Charlotta Sirén, Ludwig Plasswilm y Paul M. Putora. "Treatment Options in Oncology". JCO Clinical Cancer Informatics, n.º 2 (diciembre de 2018): 1–10. http://dx.doi.org/10.1200/cci.18.00017.

Texto completo
Resumen
Multiple treatment strategies exist for many oncologic problems. In this review, we provide a summary of various reasons for the existence of multiple treatment options in oncology, including factors that concern the treating physician (eg, treatment preferences), environmental factors (eg, financial, regulatory, and scientific aspects), and individual patient-specific factors (eg, medical condition, preferences). We demonstrate the vital role of available treatment options and their origins for clinical decision making and patient communication. These aspects are particularly helpful in the process of shared decision making, which is increasingly favored in situations where there are multiple medically reasonable options.
Los estilos APA, Harvard, Vancouver, ISO, etc.
41

Nesbitt, Shawna D. "Treatment options for prehypertension". Current Opinion in Nephrology and Hypertension 16, n.º 3 (mayo de 2007): 250–55. http://dx.doi.org/10.1097/mnh.0b013e3280c8eebe.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
42

Young, William F. "Primary aldosteronism – treatment options". Growth Hormone & IGF Research 13 (agosto de 2003): S102—S108. http://dx.doi.org/10.1016/s1096-6374(03)00064-9.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
43

Butt, W. E. "AURICULAR HAEMATOMA—TREATMENT OPTIONS". ANZ Journal of Surgery 57, n.º 6 (junio de 1987): 391–92. http://dx.doi.org/10.1111/j.1445-2197.1987.tb01382.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
44

Goodrich, L. R. y A. J. Nixon. "Treatment options for osteomyelitis". Equine Veterinary Education 16, n.º 5 (5 de enero de 2010): 267–80. http://dx.doi.org/10.1111/j.2042-3292.2004.tb00310.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
45

Gwiazda, Jane. "Treatment Options for Myopia". Optometry and Vision Science 86, n.º 6 (junio de 2009): 624–28. http://dx.doi.org/10.1097/opx.0b013e3181a6a225.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
46

Friman, S. "Cholangiocarcinoma — Current Treatment Options". Scandinavian Journal of Surgery 100, n.º 1 (marzo de 2011): 30–34. http://dx.doi.org/10.1177/145749691110000106.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
47

Strupp, M. y T. Brandt. "Neurology - Current treatment options". DMW - Deutsche Medizinische Wochenschrift 130, n.º 25/26 (junio de 2005): 1536–39. http://dx.doi.org/10.1055/s-2005-870858.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
48

Little, B. y M. White. "Treatment options for paraphimosis". International Journal of Clinical Practice 59, n.º 5 (6 de enero de 2005): 591–93. http://dx.doi.org/10.1111/j.1742-1241.2004.00356.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
49

Bashir, H. y J. Jankovic. "Treatment options for chorea". Expert Review of Neurotherapeutics 18, n.º 1 (15 de noviembre de 2017): 51–63. http://dx.doi.org/10.1080/14737175.2018.1403899.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
50

Kraft, Tom. "Treatment Options for Snoring". Journal of the Royal Society of Medicine 96, n.º 9 (septiembre de 2003): 473. http://dx.doi.org/10.1177/014107680309600924.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía